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Human synovial explants in culture release material that stimulates the production of prostaglandin E, 
(PGE,) and several extracellular enzymes by human chondrocytes. Fractionation of conditioned medium 
by gel filtration revealed a protein of approx. 15 kDa, which in addition to stimulating production of PGE, 
and plasminogen activator by human articular chondrocytes, possessed interleukin 1 activity and induced 
cartilage degradation. Further purification using iso-electric focussing again showed co-elution of these ac- 
tivities with a major pi of 6.9 and a minor pl of 5.1-5.3. This study indicated that human synovium releases 
a facor that is closely related to or identical with interleukin 1 and suggests that this protein may participate 
in cellular interactions that occur within the rheumatoid joint. 
Cartilage Chondrocyte Interleukin I Prostaglandin E Rheumatoid arthritis Synovium 
1. INTRODUCTION 
Although the causes of rheumatoid arthritis re- 
main obscure, there is now considerable evidence 
that some of the pathological events may be 
mediated by interaction between cell types within 
the rheumatoid joint. Authors in [l] showed that 
when porcine synovium and cartilage were main- 
tained in the same organ co-culture system, 
destruction of cartilage matrix took place. They 
suggested that cultured synovial tissue released a 
factor (later termed ‘catabolin’) [2] which induced 
chrondrocytes to degrade their own matrix, since 
degradation only occurred if the cartilage was 
viable. Further work by authors in [3] showed that 
conditioned medium from human synovium also 
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Abbreviations: PGEz, prostaglandin Ez; IL-l, in- 
terleukin 1; PA, plasminogen activator; FCS, fetal calf 
serum; LAF, lymphocyte activating factor 
stimulated cartilage-resorption whilst studies in 
our laboratory [4] indicated that such medium 
stimulated the production of PGEz and PA by 
isolated human chondrocytes, an activity we at- 
tributed to ‘synovial factor’ (SF). It was found [5] 
that normal blood monocytes release in culture a 
soluble factor (termed mononuclear factor, MCF) 
that stimulated the production of prostaglandin E 
and collagenase by cells isolated from human 
rheumatoid synovium. Factors derived from 
synovium and mononuclear cells may be important 
mediators of rheumatoid arthritis since they are 
produced by, and act upon, cell types known to be 
present at potential sites of inflammation and con- 
nective tissue degradation. 
Investigation into the identity of MCF revealed 
a protein that appeared to be very similar to IL-l 
[a], a monokine previously shown to modulate a 
variety of immunological functions [7,8]. Subse- 
quent studies in our laboratory [9,10] using partial- 
ly purified human IL-l have shown that IL-I 
possesses the ability to stimulate the production of 
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enzymes and PGE2 by isolated human articular 
chondrocytes and to induce both degradation of 
cartilage and bone resorption, activities that had 
previously been attributed to MCF [ 1 l- 131. Since 
there appeared to be many similarities between the 
connective-tissue activators, we have investigated 
further the profile of biological activity of a more 
purified SF, which unlike the other factors, had 
not been resolved further than gel filtration. 
Purification from the conditioned medium of nor- 
mal human synovial explants was carried out using 
gel filtration followed by iso-electric focussing, 
and biological activity assessed using the standard 
assays for IL-l (murine thymocyte proliferation), 
catabolin (release of glycosaminoglycan from ex- 
plants of bovine nasal cartilage) and MCF (pro- 
duction of PGEz and enzymes by isolated human 
chondrocytes). 
2. EXPERIMENTAL 
2.1. Production and purification of SF 
Specimens of normal synovium were obtained 
from adult human knee joints after surgical am- 
putation for lower limb ischaemia or trauma. The 
synovium was freed from surrounding tissues by 
microdissection and cultured as small explants (ap- 
prox. 20-30 mg tissue), cultures contained 1 g 
(wet wt) of tissue per 10 ml minimal essential 
medium supplemented with 10% FCS plus 
100 U/ml penicillin and 100 pg/ml streptomycin. 
After 3 days of culture, conditioned medium con- 
taining SF was removed and stored at -20°C. 
Medium from 6-8 SF preparations was pooled, 
freeze-dried and reconstituted in 50 mM am- 
monium acetate buffer (pH 7.4) and applied to an 
80 x 4.4 cm column of BioGel P30, equilibrated in 
50 mM ammonium acetate. Fractions eluting with 
an apparent molecular mass of 15 (? 2.5) kDa 
were pooled and dialysed against 0.5% (w/v) 
glycine. The dialysed material was then further 
fractionated in an LKB preparative iso-electric 
focussing apparatus using a beaded gel containing 
1.6% (w/v) ampholines (pH 3.5-10) and 0.4% 
(w/v) ampholines (pH 7-9). After completion of 
focussing the gel bed was divided into 30 fractions 
and the material contained in each fraction eluted 
with 1.5 ml distilled water, the pH recorded, and 
the gel further eluted with 1.5 ml phosphate- 
buffered saline. Fractions were dialysed against 
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phosphate-buffered saline (3 changes) and stored 
at -20°C until assay. 
2.2. Human chondrocyte culture techniques 
Slices of normal articular cartilage were taken 
from the femoral and tibia1 condyles of human 
knee joints obtained after surgical amputation for 
lower limb ischaemia or trauma. Chondrocytes 
were dispersed by sequential digestion and cultured 
as in [9]. Prostaglandins in the culture media were 
measured by radioimmunoassay [14] utilising an 
antiserum with specificity towards PGE2 (Steranti 
Research, St Albans, England). Production of 
plasminogen activator by chondrocytes was 
measured as in [15]. 
2.3. Cartilage resorption assay 
This was performed as described [9], results be- 
ing expressed as % total chondroitin sulphate 
released from fragments of bovine nasal cartilage 
over an 8-day incubation period. 
2.4. IL-l assay 
IL-l activity was measured by the enhancement 
of lectin-stimulated mouse thymocyte proliferation 
(the lymphocyte activating factor, LAF, assay). 
Murine thymocytes (2 x lo6 per well) were cultured 
for 72 h in 200 ~1 RPM1 1640, supplemented with 
5% FCS, antibiotics and 2.5 x 10v5 M mercap- 
toethanol in microtest trays. Cells were stimulated 
with test materials and phytohaemagglutinin 
(1 pg/ml). Cultures were pulse-labelled for the last 
18 h with 0.5 &i/well [3H]thymidine and 
harvested with an automatic cell harvester 
(‘Titertek’, Flow Laboratories, Irvine, Scotland). 
3. RESULTS 
Fig.1 shows gel filtration profiles of SF condi- 
tioned medium. The activity originally ascribed to 
the factor, namely the ability to stimulate produc- 
tion of PGE2 and PA by chondrocytes, co-elutes 
with IL-l (LAF) activity at approx. 15 kDa, which 
is the characteristic molecular mass of IL-l. The 
15-kDa peak also induces the release of chon- 
droitin sulphate from bovine nasal cartilage. A 
smaller activity at higher molecular mass is pre- 
sent, which has also been observed after gel filtra- 
tion of human synovial catabolin, and may be 
caused by aggregation of the protein of the main 
Volume 179, number 2 FEBS LETTERS January 1985 
70 - 
60 
50 . 
40 
30 . 
2 
26 
POE2 and PA 
I& 
80 Z 
24 
1 
zl 
60 
22 
I I ; 20 40 
?I 
18 
20 
16 
0 0 
3yI 41R 4WiU 57B Bw 73w 
Fraction Number 
Fig.1. Gel filtration chromatography of IL-l (LAF), 
cartilage-degrading and chondrocyte-stimulating ac- 
tivities. 20 ml of the synovial explant culture fluid 
concentrate was chromatographed over BioGel P30 in 
50 mM ammonium acetate, pH 7.4. Fractions were 
tested for IL-l activity at 2% dilution, chondrocyte- 
stimulating activity at 4%, and for the ability to induce 
cartilage degradation at 10% dilution. 
peak [3]. Fig.2 shows the results from further frac- 
tionation of SF by isoelectric focussing of the 
15kDa peak obtained by gel filtration. A major 
peak of IL-l activity occurs at a pZ of 6.9 and a 
minor peak is present between pZ 5.1 and 5.3. This 
pattern of iso-electric points is typical of that 
observed for human IL-l [lo]. Both the cartilage- 
degrading and chondrocyte-stimulating activities 
follow the IL-l profile. This suggests that the same 
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Fig.2. Distribution of the biological activities of SF on 
iso-electric focussing. The 15 (f 2.5) kDa SF-rich 
fraction obtained by gel filtration chromatography of 
synovial explant conditioned medium was further 
fractionated by iso-electric focussing and the fractions 
dialysed against phosphate buffered saline. Fractions 
were tested for IL-l activity at a dilution of 2%, for 
chondrocyte-stimulating activity at 4% dilution and for 
the induction of cartilage degradation at 10% dilution. 
molecule, or closely related family of molecules, is 
responsible for all the activities observed. 
4. DISCUSSION 
By gel filtration and iso-electric focussing, SF 
exhibited properties that did not distinguish it 
from IL-l. To our knowledge, this is the first 
report of the production of IL-l activity by human 
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synovial tissue. The presence of IL-l activity in the 
synovial fluids has been observed [ 16- 181. In [ 171 
no correlation was found between the number of 
macrophages, and the amount of IL-1 present in 
synovial fluids. It is therefore possible that the 
synovium is a significant source of the IL-l present 
in the joint fluids. IL-l derived from the synovium 
may be produced by the type A synovial lining 
cells, which are thought to belong to the 
mononuclear phagocyte system and possess recep- 
tors for complement factor C3 and IgG Fc 
[19-211, or from cells not of the monocyte/ 
macrophage lineage, as has been described for 
other tissues [7]. 
Our finding suggest hat the synovium may con- 
tribute to the pathology of rheumatoid arthritis 
not only by the release of proteolytic enzymes but 
also through the secretion of IL-l. These results, 
together with those in [9], mentioned above, show 
that cartilage degradation can be mediated by IL-l 
through the induction of chondrocyte catabolic ac- 
tivity. This could occur in vivo following cellular 
activation by IL-1 derived from the invading 
synovial pannus. Such IL-l would also affect im- 
mune cells present either in the synovial fluids or 
in the synovium itself. Cells resembling T- 
lymphocytes and plasma cells containing IgG, as 
well as monocytes, have been identified in 
rheumatoid synovial tissue [22-241. Co-operation 
between these cell types may contribute to the 
characteristic hronicity of the disease through the 
continued activation of monocyte/macrophages 
and subsequent release of further IL-l into the 
joint tissues. 
Another interesting finding is that the major 
cartilage-degrading activity of SF occurs at a dif- 
ferent pZ to that previously described for 
catabolin. Partially purified human synovial 
catabolin is reported to be an acidic protein, with 
a pZ of 5.2-5.3, there being no apparent 
biologically active species with neutral pZ [3]. SF 
however, has a major peak with a pZ of 6.9 in addi- 
tion to the acidic peak characteristic of catabolin. 
The reason for this discrepancy is at present 
unknown, although reports on catabolin have only 
involved the use of the cartilage-degradation assay, 
and further investigation of its biological activity 
by the assays for IL-l and MCF used above, wouhi 
help to clarify its relationship to IL-l/MCF/SF. 
Our finding that human synovium produces a 
250 
factor biochemically indistinguishable from IL-l 
suggests that cellular interactions within the 
rheumatoid joint, leading to the destruction of car- 
tilage, may be mediated by the family of related 
peptides comprising IL-l. Confirmation of this 
hypothesis however, awaits further characterisa- 
tion of IL-l by monoclonal antibodies and by pep- 
tide and gene sequencing. 
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